The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Condition:   Gastroesophageal Junction (GEJ) Adenocarcinoma Intervention:   Drug: Q-1802 Injection,Oxaliplatin Injection,Capecitabine Sponsor:   QureBio Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials